Mania from PCP

Mania in the context of psychoactive substance use refers to a state of pathologically elevated mood, energy, and psychomotor activity that goes beyond the normal stimulant or euphoric effects of a substance into a qualitatively different and clinically significant syndrome. Substance-induced mania shares most features with the manic episodes of bipolar disorder but is precipitated by pharmacological intervention rather than endogenous mood cycling.

The core features of mania include persistently elevated, expansive, or irritable mood; markedly increased energy and activity; decreased need for sleep (feeling rested after only a few hours, or none at all); pressured speech (rapid, loud, difficult to interrupt); flight of ideas or racing thoughts; increased goal-directed activity or psychomotor agitation; excessive involvement in pleasurable activities with high potential for painful consequences (spending sprees, sexual indiscretions, reckless investments); and grandiosity that may reach delusional proportions.

The neurochemistry of mania involves dysregulated dopaminergic and noradrenergic signaling in prefrontal, limbic, and striatal circuits. Stimulants can trigger mania by flooding these circuits with catecholamines beyond the level that produces normal stimulant euphoria. The risk is highest during stimulant binges where sleep deprivation compounds the pharmacological effects -- after 48-72 hours of continuous wakefulness, the combination of catecholaminergic excess and sleep deprivation-induced cognitive impairment can push the individual into a frankly manic state.

Certain medications can also precipitate mania. Antidepressants, particularly SSRIs and SNRIs, can trigger manic episodes in individuals with undiagnosed bipolar disorder (a phenomenon called antidepressant-induced mania or "switching"). Corticosteroids, thyroid hormone supplementation, and some dopaminergic medications (L-DOPA, pramipexole) have also been associated with mania induction. The combination of multiple serotonergic substances can produce a state with manic features as part of serotonin syndrome.

The transition from substance-induced euphoria to mania may be gradual, and the individual experiencing it is often the last to recognize the change. Warning signs include sleep going from reduced to apparently unnecessary, confidence escalating to grandiosity, productive energy becoming unfocused agitation, and social engagement becoming pressured and boundary-violating. A sober observer who knows the individual's baseline behavior is often the first to recognize manic features.

Substance-induced mania typically resolves within days to weeks of substance discontinuation, though it may require psychiatric intervention including mood stabilizers (lithium, valproate), antipsychotics (olanzapine, quetiapine), and benzodiazepines for acute agitation. In some cases, substance-induced mania unmasks an underlying bipolar disorder that persists beyond the acute episode.